PREVALENCE OF CO-MORBIDITIES AMONG FATAL COVID-19 CASES IN KABUL, AFGHANISTAN: A CROSS-SECTIONAL STUDY
Keywords:
Co-morbidity, COVID-19, Afghan-Japan Hospital, AfghanistanAbstract
Background: Coronavirus Disease (COVID-19) is an infectious illness caused by the novel coronavirus known as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This study explored the prevalence of co-morbidities among fatal COVID-19 cases admitted to the Afghan-Japan Communicable Diseases hospital in Kabul, Afghanistan.
Methods: a descriptive cross-sectional study was carried out in Afghan-Japan Communicable Diseases Hospital, Kabul, Afghanistan. The data of fatal COVID-19 cases admitted to this hospital between 20 May and 20 June 2020 was retrospectively retrieved from the patients' documents in the hospital medical records department.
Results: During the study period total of 50 Covid-19 patients died in Afghan-Japan Communicable Diseases Hospital whose diagnosis was confirmed by RT-PCR test. 33 (66%) were males, and 17 (34%) were females. Their mean age was 12.67± 57.6 years. Most patients were aged 50-60 years, and the least were aged 30-40 years. In terms of occupation, 16(32%) were housewives, 9(18%) were unemployed, 7(14%) were teachers, 5(10%) were government officials, 2(4%) were carpenters, 2(4%) were businessmen, 2(4%) were laborers, 1(2%) were doctor, 1(2%) were shopkeeper. 49(98%) were residents of Kabul, while 1(2%) was resident of other provinces. 5 patients (10%) had hypertension, 4(8%) had chronic renal failure, 1 (2%) had chronic obstructive pulmonary disease, and 38 patients (76%) had no co-morbidities.
Conclusion: Most of the fatal COVID-19 cases in this study were men aged 50-60 years and residing in Kabul. Hypertension, chronic renal failure, and chronic obstructive pulmonary disease were the co-morbidities, respectively.
Downloads
Downloads
Published
Issue
Section
License
Authors who publish with Afghan Medical Journal (AMJ) agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication.
- Articles are published under a Creative Commons license.
This license permits:
- Sharing and redistribution of the material in any medium or format
- Adaptation and use for non-commercial purposes (with proper citation)
Users must:
- Give appropriate credit to the original author(s)
- Provide a link to the license
- Indicate if changes were made
No additional restrictions may be applied beyond those of the license.
The journal supports open access and the free dissemination of scientific knowledge.